|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:activeIngredient
|
pneumococcal polysaccharide conjugated to CRM197 protein
|
|
gptkbp:age
|
adults 18 years and older
children 6 weeks and older
|
|
gptkbp:alternativeTo
|
gptkb:Pneumovax_23
gptkb:Prevnar_13
|
|
gptkbp:approvalYear
|
2021
|
|
gptkbp:approvedBy
|
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:ATCCode
|
J07AL03
|
|
gptkbp:containsSerotype
|
gptkb:18C
gptkb:19F
gptkb:23F
1
14
3
4
5
6B
9V
6A
19A
7F
22F
33F
|
|
gptkbp:countryOfOperation
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:form
|
suspension for injection
|
|
gptkbp:indication
|
prevention of invasive disease caused by Streptococcus pneumoniae
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:storage
|
2°C to 8°C
|
|
gptkbp:targetPathogen
|
gptkb:Streptococcus_pneumoniae
|
|
gptkbp:vaccineType
|
gptkb:vaccine
|
|
gptkbp:bfsParent
|
gptkb:Merck_Sharp_&_Dohme
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vaxneuvance
|